Imago Biosciences Inc (IMGO) Stock
IMGO is no longer traded. Imago Biosciences was acquired by Merck (MRK) on January 11, 2023.
Each IMGO share was exchanged for $36.00 in cash. Prices on this page are historical; the last trade was January 10, 2023 at $36.01.
See Merck (MRK) stock →Imago Biosciences stock price history
IMGO final trading statistics
- Final close
- $36.01
- Final trading day
- Jan 10, 2023
- Market cap at delisting
- $1.22B
- Shares outstanding
- 33.84M
- Final 52-week range
- $11.56 – $36.09
- Avg. volume (final 3 mo.)
- 757,710
- All-time high (split-adj.)
- $36.01 · Jan 2023
- All-time low (split-adj.)
- $11.81 · Jun 2022
- Return since IPO
- +125.1%
- Beta
- —
- Book value / share
- $5.11
- Price / book
- 7.05
Imago Biosciences annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $0.00 | -$42.3M | -$9.58 |
| FY2020 | $0.00 | -$17.8M | -$0.82 |
| FY2019 | $0.00 | -$10.9M | -$0.50 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Imago Biosciences Inc
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California. As of January 11, 2023, Imago BioSciences, Inc. operates as a subsidiary of Merck Sharp & Dohme Corp..
Imago Biosciences stock FAQ
What happened to Imago Biosciences stock?
Imago Biosciences was acquired by Merck (MRK) on January 11, 2023. Shareholders received $36.00 in cash for each share. IMGO stock stopped trading on the Nasdaq, with a final close of $36.01 on January 10, 2023.
What did Imago Biosciences shareholders receive?
Each IMGO share was converted into $36.00 in cash. The deal was valued at about $1.35 billion.
Is IMGO stock still trading?
No. IMGO was delisted from the Nasdaq on January 11, 2023 and no longer trades on a U.S. exchange.
What was the last price of IMGO stock?
IMGO closed at $36.01 on its final trading day, January 10, 2023, for a market value of about $1.22B.
What were Imago Biosciences's revenue and earnings in its last full fiscal year?
Imago Biosciences reported revenue of $0.00 and net income of -$42.3M in fiscal 2021, its last full year as a public company.
When did Imago Biosciences go public?
Imago Biosciences Inc stock began trading on July 16, 2021.